SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

RaveDAO is a global community uniting music, technology, and purpose. Since their first sold-out event at Dubai 2024, they have expanded across Europe, the Middle East, North America, and Asia, hosting world-class experiences with over 100,000 total attendees and 3,000+ attendees for each event.  RaveDAO has worked with top-tier artists like Vintage Culture, Don Diablo, Chris Avantgarde, Lilly Palmer, MORTEN, Bassjackers, and GENESI and has support from Binance, OKX, Bitget, and Polygon. RaveDAO is redefining live entertainment in Web3 and has active partnerships with 1001Tracklists, AMF, and Warner Music.  Beyond the dance floor, RaveDAO channels energy and attention toward impact. In 2025 alone, proceeds from its events helped restore sight to 400+ cataract patients in Nepal and fund over 150 meditation programs across the U.S.

RaveDAO

RaveDAO is experiencing intense volatility, with the community actively debating whether the token is primed for a massive short squeeze or trapped in a persistent pump-and-dump cycle. Retail traders remain deeply divided, with some aggressively loading up on dips while others express concerns over potential manipulation and a lack of official communication.

Churchill Capital Corp. XI is a blank check company. It was formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses. The company was founded by Michael Stuart Klein on June 4, 2025 and is headquartered in New York, NY.

Churchill Capital Corp XI - Ordinary Shares - Class A

Churchill Capital Corp XI is currently attracting significant attention due to its pending merger with Agility Robotics, a move that has sparked intense debate among community members regarding its long-term potential versus concerns of a pump-and-dump scheme. Investors are actively discussing the company's backing by major technology and industrial giants, weighing the risks of SPAC-related volatility against the speculative appeal of the emerging humanoid robotics sector.

Evolution Metals & Technologies Corp. engages in developing a global supply chain for critical minerals and materials. It focuses on automotive, renewable energy, and military and defense sectors. The company is headquartered in West Palm Beach, FL.

Evolution Metals & Technologies Corp.

Evolution Metals & Technologies Corp. Common Stock

Evolution Metals & Technologies Corp. is trending as investors debate the company's progress in establishing domestic rare earth magnet processing capabilities to bypass Chinese supply chains, a move central to upcoming defense sourcing mandates. While some community members highlight the potential for long-term growth driven by federal procurement policy and strategic infrastructure investments, others express caution regarding potential market manipulation and the execution risks associated with scaling operations.

NEAR Protocol is the blockchain for AI. A high-performance, AI-native platform built to power the next generation of decentralized applications and intelligent agents. It provides the infrastructure AI needs to transact, operate, and interact across Web2 and Web3. NEAR combines three core elements: User-Owned AI, which ensures agents act in users’ best interests; Intents and Chain Abstraction, which eliminate blockchain complexity for seamless, goal-driven transactions across chains; and a sharded blockchain architecture that delivers the scalability, speed, and low-cost execution needed for real-world AI and Web3 use. This integrated stack makes NEAR the foundation for building secure, user-owned, AI-native applications at internet scale.

Near

NEAR is trending as investors focus on its role in the AI-agent infrastructure space, with many in the community highlighting the protocol's chain abstraction and recent developments in privacy-preserving technology. While some traders are capitalizing on high volatility with short-term strategies, long-term holders remain active, weighing the potential for utility-driven growth against broader market corrections.

BlackRock, Inc. engages in the provision of investment, advisory, and risk management solutions. Its products include single-asset and multi-asset portfolios. The company was founded by Laurence Douglas Fink and Robert Steven Kapito in 1988 and is headquartered in New York, NY.

Blackrock Inc.

BlackRock shares faced a sharp sell-off as the asset manager capped withdrawals from its private credit fund following redemption requests that exceeded the quarterly limit. The community is actively debating the health of the broader private credit sector, with investors drawing comparisons to past liquidity crises while others monitor potential contagion risks across alternative asset managers.

Bullish engages in the management of a digital asset platform. It also offers market infrastructure and information services. The company was founded by Brendan Francis Blumer in 2020 and is headquartered in George Town, Cayman Islands.

Bullish

Bullish is trending as investors weigh its aggressive expansion, including the acquisition of Equiniti, against significant volatility in crypto markets and mixed earnings reports. The community remains deeply divided, with some investors betting on the stock as a long-term infrastructure play backed by institutional accumulation, while critics express frustration over the stock's persistent downward trend since its IPO.

Jabil, Inc. engages in the provision of manufacturing services and solutions. It operates through the Electronics Manufacturing Services (EMS) and Diversified Manufacturing Services (DMS) segments. The EMS segment focuses on leveraging information technology, supply chain design and engineering, technologies largely centered on core electronics, utilizing a large-scale manufacturing infrastructure, and the ability to serve a broad range of end markets. The DMS segment offers engineering solutions with an emphasis on material sciences, machining, tooling, and molding of engineered plastic and metal parts. The company was founded by William E. Morean and James Golden in 1966 and is headquartered in St. Petersburg, FL.

Jabil Inc

Jabil Inc. is trending as investors digest strong fiscal quarterly results that topped expectations and a new billion-dollar share repurchase authorization. The stock is drawing significant attention from the community due to its pivotal role as a hardware backbone for AI data center infrastructure and cloud expansion, keeping sentiment bullish as the company navigates stabilizing demand across its diverse end-markets.

Eli Lilly & Co. engages in the discovery, development, manufacture, and sale of pharmaceutical products. The firm's products include diabetes, oncology, immunology, neuroscience, and other products and therapies. The company was founded by Eli Lilly on May 10, 1876 and is headquartered in Indianapolis, IN.

Lilly(Eli) & Co

Eli Lilly is trending as investors rotate into defensive healthcare stocks, further fueled by highly positive phase 3 data for its obesity drug retatrutide. The community is actively discussing the company's aggressive acquisition strategy, its competitive lead in the GLP-1 sector, and the potential for long-term growth as capital shifts away from high-beta technology shares.

Oatly Group AB is a holding company, which focuses on developing expertise around oats, a global power crop with inherent properties suited for sustainability and human health. It operates through the following geographical segments: Europe & International, North America and Greater China. The company was founded by Björn Öste in 1994 and is headquartered in Malmö, Sweden.

Oatly Group AB - ADR

Oatly Group

Oatly is currently a major focus for investors as the community eagerly awaits a potential China carve-out to stabilize the balance sheet and bolster liquidity. Despite concerns over debt and share price performance, there is significant enthusiasm surrounding the company's expansion into new product categories like matcha and cold foam, which many hope will drive the next wave of profitable growth.

Mastercard, Inc. is a technology company, which engages in the provision of payment solutions for the development and implementation of credit, debit, prepaid, commercial, and payment programs through its brands including Mastercard, Maestro, and Cirrus. It also offers cyber and intelligence solutions. The company was founded in November 1966 and is headquartered in Purchase, NY.

Mastercard Incorporated - Ordinary Shares - Class A

Mastercard Inc

Mastercard is trending as investors weigh strong earnings growth and a robust shift toward value-added services against regulatory pressure from proposed credit card interest rate caps and interchange fee legislation. While some in the community see the current volatility as a discount opportunity for a resilient compounder, others remain cautious due to ongoing institutional uncertainty and debates over the long-term impact of AI-driven payment solutions.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

The Biology Came First.

MindWalk Holdings Corp. (NASDAQ: HYFT) today released a systematic report identifying over 20 discovery-originated drug candidates with documented origins in antibody discovery work performed at...

Xencor (XNCR) Reports Q1 Loss, Lags Revenue Estimates

Xencor (XNCR) delivered earnings and revenue surprises of -164.58% and -75.38%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Xencor Reports First Quarter 2026 Financial Results

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today reported financial results for the...

Xencor Highlights XmAb942 Phase 1 Data, Previews TL1A/IL-23 Bispecific XmAb412 at DDW 2026

Xencor (NASDAQ:XNCR) used a webcast during Digestive Disease Week 2026 to highlight Phase I results for its TL1A-targeting monoclonal antibody XmAb942 and to outline preclinical data supporting...

Xencor to Host Webcast to Discuss XmAb942 and XmAb412 Data Presentations at DDW

Xencor, Inc. (NASDAQ:XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies for the treatment of cancer and autoimmune diseases, today reported final results from the...

Corcept Therapeutics (CORT) Reports Q1 Loss, Misses Revenue Estimates

Corcept (CORT) delivered earnings and revenue surprises of -1.11% and -4.37%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

Xencor (XNCR) Projected to Post Earnings on Wednesday

Xencor (NASDAQ:XNCR) will be releasing its Q1 2026 earnings before the market opens on Wednesday, May 6. (View Earnings Report at https://www.marketbeat.com/earnings/reports/2026-5-6-xencor-inc-stock...

Xencor, Inc. (NASDAQ:XNCR) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Shares of Xencor, Inc. (NASDAQ:XNCR - Get Free Report) have received a consensus rating of "Moderate Buy" from the nine analysts that are covering the stock, Marketbeat Ratings reports. One research analyst has rated the stock with a sell rating, two have assigned a hold rating and six have assig...

Xencor (NASDAQ:XNCR) Stock Price Down 8% - Should You Sell?

Xencor (NASDAQ:XNCR) Shares Down 8% - Here's What Happened...

Xencor (NASDAQ:XNCR) Stock Passes Above 50 Day Moving Average - Time to Sell?

Xencor (NASDAQ:XNCR) Stock Price Passes Above 50-Day Moving Average - What's Next...

Xencor, Inc. is a biopharmaceutical company, which engages in the development of engineered monoclonal antibody therapeutics to treat severe and life-threatening diseases. Its proprietary technology platform, XmAb, is used to create next-generation antibody product candidates designed to treat autoimmune and allergic diseases, cancer, and other conditions. The company was founded by Bassil I. Dahiyat and Stephen L. Mayo in August 1997 and is headquartered in Pasadena, CA.

Xencor Inc

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$15.05
Prev Close	$14.74
Open	$14.82
Dividend Yield	0.00%
50-Day Moving Average	$12.31
Beta	1.42
Avg. Volume	751,570.15
PE Ratio	-6.41

52-Week High	$18.69
52-Week Low	$6.92
Market Capitalization	$1.12B
EPS (Annual)	-$1.24
Price to Book	2.12
Revenue Per Employee	$482,984.61

Feed

News

Sentiment

Earnings

Fundamentals

Info

XNCRXencor Inc

Latest XNCR News